We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.AMENDED AND RESTATED LICENSE AGREEMENT By and Between PRESIDIO PHARMACEUTICALS, INC. And XTL BIOPHARMACEUTICALS LTD.License Agreement • April 6th, 2009 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledApril 6th, 2009 Company Industry JurisdictionThis Amended and Restated License Agreement (this “Agreement”), dated the 4th day of August, 2008 (the “Restatement Date”), is by and between Presidio Pharmaceuticals, Inc., a Delaware corporation (“PRESIDIO”), and XTL Biopharmaceuticals Ltd., a public company limited by shares organized under the laws of Israel (“XTL”).
LICENSE AGREEMENT By and Between PRESIDIO PHARMACEUTICALS, INC. and XTL BIOPHARMACEUTICALS LTD.License Agreement • March 27th, 2008 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2008 Company Industry JurisdictionThis License Agreement (this “Agreement”), dated the 19th day of March, 2008 (the “Effective Date”), is by and between Presidio Pharmaceuticals, Inc., a Delaware corporation (“PRESIDIO”), and XTL Biopharmaceuticals Ltd., a public company limited by shares organized under the laws of Israel (“XTL”).